Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuko Akaishi
Observed name:
Yuko Akaisi
Institution:
Osaka City General Hospital
Observed institutions:
Osaka City General Hospital,
Nippon Medical School
ORCID:
0000-0001-5333-4539
Observed ORCID:
0000-0001-5333-4539
OpenAlex ID:
A5049700576
Reliability of Cancer Treatment Information on the Internet: Observational Study
2018
·
Ryo Ogasawara
, Noriyuki Katsumata
, et al.
·
JMIR Cancer
·
18
[Five Cases of Pseudocirrhosis during Eribulin Treatment for Breast Cancer].
2024
·
Yuko Akaishi
, Shinya Tokunaga
, et al.
·
PubMed
·
1
MO58-2 Differences in treatment response to CDK4/6 inhibitors and endocrine therapy between HER2-negative and HER2-low expression groups
2023
·
Reo Omori
, Shinya Tokunaga
, et al.
·
Annals of Oncology
The difference in efficacy of the endocrine therapy between the HER2-low and HER2-zero metastatic breast cancer: A single-center retrospective study.
2023
·
Reo Omori
, Yuichiro Nishibori
, et al.
·
JCO Global Oncology
PDF
Abstract OT2-19-02: Clinical evaluation of the efficacy and liquid molecular analysis of abemaciclib rechallenge upon progression to abemaciclib combination therapies for ER-positive HER2-negative metastatic breast cancer patients
2022
·
Meiko Nishimura
, Takahiro Kogawa
, et al.
·
Cancer Research
P56-7 A case of Nuclear protein in testis (NUT) midline carcinoma with response to Ewing sarcoma-based chemotherapy regimen
2021
·
Yuki Nakatani
, Yuko Akaisi
, et al.
·
Annals of Oncology
PDF
Show more works
View as search
Works count:
6
Citation count:
19
H-index:
1
I10-index:
1
Year
Topic
Type